Filing Details

Accession Number:
0001127602-12-035303
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-31 17:22:19
Reporting Period:
2012-12-28
Filing Date:
2012-12-31
Accepted Time:
2012-12-31 17:22:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235598 M James Frates Connaught House
1 Burlington Road
Dublin 4 Ireland
Svp & Cfo, Alkermes Plc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2012-12-28 3,752 $18.76 95,959 No 4 S Direct
Ordinary Shares Disposition 2012-12-31 3,752 $18.33 92,207 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 4,000 Indirect By Sons
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.66 to $18.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.25 to $18.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.